Ispecimen Inc (ISPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -4,652 | -4,727 | N/A | N/A |
| Depreciation Amortization | 963 | 1,187 | N/A | N/A |
| Accounts receivable | -999 | -113 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,055 | 41 | N/A | N/A |
| Other Working Capital | 3,041 | 1,051 | N/A | N/A |
| Other Operating Activity | 305 | -118 | 0 | 0 |
| Operating Cash Flow | $-288 | $-2,680 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -1,103 | -1,475 | N/A | N/A |
| Investing Cash Flow | $-1,103 | $-1,475 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 2,033 | 3,075 | N/A | N/A |
| Common Stock Issued | 0 | 4 | N/A | N/A |
| Financing Cash Flow | $2,033 | $3,079 | $N/A | $N/A |
| Beginning Cash Position | 54 | 1,130 | N/A | N/A |
| End Cash Position | 696 | 54 | N/A | N/A |
| Net Cash Flow | $642 | $-1,077 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -288 | -2,680 | N/A | N/A |
| Capital Expenditure | -1,103 | -1,475 | N/A | N/A |
| Free Cash Flow | -1,391 | -4,155 | 0 | 0 |